Chemed Total Non-Operating Income/Expense 2010-2024 | CHE

Chemed total non-operating income/expense for the twelve months ending June 30, 2024 was $0.028B, a 789.49% decline year-over-year.

  • Chemed annual total non-operating income/expense for 2023 was $0.01B, a 170.91% decline from 2022.
  • Chemed annual total non-operating income/expense for 2022 was $-0.014B, a 289.9% decline from 2021.
  • Chemed annual total non-operating income/expense for 2021 was $0.007B, a 15.31% increase from 2020.

Chemed Total Non-Operating Income/Expense 2010-2024 | CHE

  • Chemed annual total non-operating income/expense for 2023 was $0.01B, a 170.91% decline from 2022.
  • Chemed annual total non-operating income/expense for 2022 was $-0.014B, a 289.9% decline from 2021.
  • Chemed annual total non-operating income/expense for 2021 was $0.007B, a 15.31% increase from 2020.
Related Stocks
Company NameMarket
Cap
Fresenius SE (FSNUY)$21.4B
Quest Diagnostics (DGX)$17.3B
DaVita (DVA)$13.8B
Encompass Health (EHC)$9.2B
Elanco Animal Health (ELAN)$7.1B
Option Care Health (OPCH)$5.3B
RadNet (RDNT)$4.9B
Amedisys (AMED)$3.2B
Astrana Health (ASTH)$2.7B
LifeStance Health (LFST)$2.6B
Addus HomeCare (ADUS)$2.4B
U.S Physical Therapy (USPH)$1.3B
Pennant (PNTG)$1B
Aveanna Healthcare Holdings (AVAH)$1B
Atai Life Sciences (ATAI)$215M
Daxor (DXR)$46M
ATI Physical Therapy (ATIP)$26M
MEDIROM Healthcare Technologies (MRM)$19M
Psychemedics (PMD)$14M
Ontrak (OTRK)$10M
Novo Integrated Sciences (NVOS)$5M
IMAC Holdings (BACK)$2M